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CARDIOLOGY

Shocked But Not Surprised: The Philly Cardioversion
Gillian Naro, MD, MEd1, Naman Upadhyay, MD1, Emilie Thompson, MD1, Tudor Sturzoiu, MD1
1. Division of Hospital Medicine, Department of Medicine Thomas Jefferson University Hospital, Philadelphia, PA

INTRODUCTION
Neuromuscular incapacitating devices, colloquially
known as ‘tasers’, are typically used by police and security
personnel as a non-lethal way to subdue combative
assailants. Unfortunately, there are times in the hospital
when patients can become assailants, thus potentially
necessitating the use of tasers to ensure the safety of
staff and other patients. Tasers come in several varieties.
However, those typically used by law enforcement have
a 50,000-V capacity and deliver 0.36 - 1.76 Joules of
energy per pulse, at a rate of ~20 pulses per second, via
two barbed projections1. This leads to incapacitation of
the assailant via the induction of fused muscle
contractions that preclude coordinated neuromuscular
inputs, thus inducing a near-tetanic state 2. In medicine,
we often use electricity in a coordinated manner to
convert dangerous cardiac arrhythmias back to normal
sinus rhythm. In this case, we discuss how a patient who
was admitted to the hospital in a sustained arrhythmia,
became an assailant. A taser was used to subdue him,
and we will examine how this theoretically may have
impacted his arrhythmia.

CASE
A patient with a past medical history of advanced heart
failure with reduced ejection fraction of 10% secondary
to methamphetamine use was admitted to the medical
intensive care unit for severe COVID-19 infection
resulting in hypoxic respiratory failure requiring
intubation. His acute respiratory condition stabilized,
and he was liberated from the ventilator. His oxygen
status continued to improve as he was weaned to 2L
nasal cannula, and he was transferred to a general
medicine telemetry service.
His hospital course was further complicated by
suspected in-hospital use of methamphetamines
resulting in atrial fibrillation with rapid ventricular
response with rates in the 150s. The patient reported
feeling “bad”, and he was noted to be diaphoretic and
agitated. He was started on a digoxin infusion and given
intravenous diuresis. As he experienced subjective
improvement with down trending heart rates, he asked
to leave the hospital against medical advice (AMA). On
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examination of the patient, he was unable to express
the risks of leaving the hospital and foregoing additional
medical interventions. With psychiatry input, patient
was deemed to lack capacity to leave AMA.
Patient then became angered, decannulated his
intravenous lines, removed his telemetry strips, and
attempted to leave the hospital room. He became very
aggressive with threats of violence to the medical staff,
so security was contacted. His condition visibly appeared
to deteriorate as he was in clear extremis, diaphoretic,
and weak. Even his screaming became more tired and
hoarse. Finally, after an hour of negotiation, the patient
lunged at the provider, requiring the security officer to
react by activating his taser and delivering a shock. He
was then injected with 5mg of intramuscular haloperidol
and placed in four-point restraints. The team was hopeful
that the delivery of electricity to his chest may have
restored sinus rhythm, but the patient remained in atrial
fibrillation when placed back on telemetry.

DISCUSSION
It has been previously posited that taser devices pose
minimal cardiac threat because of the depth of tissue
that must be penetrated to affect the heart, the relative
intensity of electrical energy required to activate
cardiac muscle as opposed to skeletal muscle, and the
different electric pulse widths required to activate
cardiac as opposed to skeletal muscle2. There has
been extensive original research assessing the cardiac
and even neurologic risk associated with taser devices
since their development, and this has also been
reviewed in the literature1.
Interestingly, it does appear that taser shocks can
influence cardiac activity, as was demonstrated in a
previous report outlining a pacemaker interrogation
that revealed the induction of rapid ventricular
conduction in a patient following a taser shock4.
Additionally, we were able to locate one case report of
atrial fibrillation induced in a patient with no history of
atrial fibrillation, normal electrolytes, and a structurally
normal heart following the application of a taser shock5.
In the case of our patient, there was a fleeting hope
among the care team that the taser shock could have
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successfully restored sinus rhythm via electrical
cardioversion, but this was revealed to not be the case
after he was back on telemetry after being subdued.
There are many reasons why this might be, but it seems
reasonable that inherent differences among different
brands of tasers may affect the potential of each unit to
influence myocardial conduction. Further, various
areas on the human body where this shock could be
applied, it stands to reason that there are many potential
physiologic effects of a taser shock that will not be
experienced. Additionally, the actual energy delivery
per taser shock is quite low, at around an average of 1
J per pulse among different units, and it is difficult to
quantify what additive effect the many shocks delivered
per second may have on myocardial conduction.
Research by Richard et al reports only a 22% success
rate with 50 J in external cardioversion in atrial
fibrillation, which is significantly higher than the average
J delivered per shock from a taser6,7,8. In a patient with
severe cardiomyopathy, even a coordinated shock
from a dedicated defibrillator may not be successful in
restoring sinus rhythm, so it is not entirely surprising
that a taser-mediated shock, which we fondly refer to
as a “Philly Cardioversion”, was unable to restore sinus
rhythm in this patient.
Although the authors would certainly prefer that no
additional humans undergo a taser shock, further
observation of the incidence of the resolution of
arrhythmias in the setting of taser shocks will continue
to elucidate the potential of these enforcement tools to
influence cardiac activity. Since tasers are designed to
provide a non-lethal shock, their mechanics would
ideally have very low risk myocardial involvement.
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